Company attributes
Venture Capital Firm attributes
Other attributes
The Longevity Fund is a venture capital firm in San Francisco that prefers to invest in companies that focus on extending the period of healthy human life and ameliorate age-related decline in physical function. Founded 2011 by Laura Deming in San Francisco, California, the firm invests in series A, series B, and series C rounds. The notable investment portfolio of The Longevity Fund includes Epirium Bio, eXo Imaging, Fauna Bio, Spring Discovery, System1 Biosciences, Decibel Therapeutics, Precision BioSciences, and UNITY Biotechnology. As of January 2020, The Longevity Fund has made 11 investments and two exits.